From Genome to Proteome: Integration and proteome completion - 8th Siena Meeting [0.03%]
从基因组到蛋白质组：整合与蛋白质组完善-第八届锡耶纳会议
Asa M Wheelock,Craig E Wheelock
Asa M Wheelock
The Siena Meeting is designed to cover the breadth of proteomics-based research, with a particular focus on clinical applications as well as emerging technologies. As in previous years, the 2008 meeting attracted a mix of academic, clinical...
Mats Holmqvist,Merritt Maduke
Mats Holmqvist
Select Biosciences' Fourth Annual Ion Channel Targets conference brought together scientists from industry and academia who are interested in the discovery of therapeutics targeted to various ion channels implicated in human disease. Topics...
Infectious diseases of the nervous system: pathogenesis and worldwide impact [0.03%]
神经系统感染性疾病：发病机理及全球影响
Ben Berkhout
Ben Berkhout
The 2008 Infectious Diseases of the Nervous System: Pathogenesis and World Impact conference was held at the Pasteur Institute of Paris, and was the first worldwide conference on neuroinfections. While viral encephalitis and bacterial menin...
The Future of Cancer Diagnostics: Next Generation Molecular Technologies - Cambridge Healthtech Institute's Inaugural Conference [0.03%]
下一代分子技术在癌症诊断中的应用与发展——首届Cambridge Healthtech Institute国际会议
Francis L Martin
Francis L Martin
Cambridge Health Tech Institute's first conference on 'The Future of Cancer Diagnostics: Next Generation Molecular Technologies' covered the following areas: regulatory requirements regarding the validation of new cancer diagnostics; how su...
Advances in cancer drug discovery - a British association for cancer research meeting [0.03%]
癌症药物发现进展——英国癌症研究协会会议报告摘要集
Andrew D Westwell
Andrew D Westwell
The Advances in Cancer Drug Discovery meeting, organized by the British Association for Cancer Research, attracted approximately 140 delegates from industry and academia, representing a diverse spectrum from both chemical and biological sci...
Jane Watt,Gemma Sutton
Jane Watt
The XXth International Symposium on Medicinal Chemistry (EFMC-ISMC 2008) was organized by the Austrian Chemical Society on behalf of the European Federation for Medicinal Chemistry (EFMC). Approximately 1400 scientists from 58 nations congr...
R-1626, a specific oral NS5B polymerase inhibitor of hepatitis C virus [0.03%]
一种口服C型肝炎病毒特异性的NS5B聚合酶抑制剂R-1626
Pierluigi Toniutto,Carlo Fabris,Davide Bitetto et al.
Pierluigi Toniutto et al.
Roche Holding AG is developing R-1626, an oral nucleoside inhibitor of HCV RNA polymerase. R-1626 has been demonstrated to be well absorbed and rapidly converted to the active component R-1479. The compound has demonstrated a strong capacit...
Keith Howells
Keith Howells
The implementation of a typical electronic data capture (EDC) system for clinical trials - encompassing data entry, validation and reporting tools - involves modeling electronic case report forms (eCRFs) for data that will be entered by inv...